JavaScript is required to use content on this page. Please enable JavaScript in your browser.
Arrival of International Company That Holds Promise For Addressing Global Diabetes Announced During Governor’s Recent Asia Trade Mission
ANNAPOLIS, MD—First Lady Yumi Hogan attended a ribbon-cutting ceremony on Tuesday to begin the laboratory construction and build-out of South Korean pharmaceutical company UNDBIO’s new U.S. R&D headquarters in Rockville. UNDBIO’s international arrival to Maryland was announced last month during Governor Larry Hogan’s trade and investment mission to Asia. 
“We are excited to have UNDBIO in the State of Maryland to do its life-saving work,” said Governor Hogan. “I know they had several discussions with other states to conduct their path-breaking insulin initiative there, but they ultimately recognized that our Maryland assets would give them the best chance to successfully get an insulin product quickly into the marketplace. This is yet another example of Maryland being open for business with an international company choosing our state and their direct investment helping to grow our economy.”
UNDBIO will begin R&D operations early next year of its proprietary insulin biosimilars technology at its new 25,000 square foot state-of-the-art laboratory facility. The company has committed a $100 million investment to begin the research and development phase of its insulin production. UNDBIO scientists will conduct research to develop insulin samples that will require regulatory approval from the U.S. Food and Drug Administration (FDA) to eventually enter the U.S. and global markets.
“We look forward to developing high-paying biotech jobs in Maryland to support the diabetic community,” said UNDBIO Chairman Jun Yong-soo. “There is a great need for affordable insulin in the United States, as currently 37 million people are now suffering from diabetes. In Maryland alone, 11.8% of the adult population have diagnosed diabetes. Every year an estimated 42,623 people in Maryland are diagnosed with diabetes and it costs an estimated $7 billion in Maryland each year in direct and indirect medical expenses.”
The UNDBIO U.S. R&D headquarters is located at Twin Labs in Rockville at 12441 Parklawn Drive. UNDBIO is not seeking any state or local funding support for its new headquarters construction.
The State of Maryland pledges to provide constituents, businesses, customers, and stakeholders with friendly and courteous, timely and responsive, accurate and consistent, accessible and convenient, and truthful and transparent services.
National Human Trafficking Hotline – 24/7 Confidential
© Copyright All rights reserved.
We’re available on the following channels.


By admin

Leave a Reply

Your email address will not be published. Required fields are marked *